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Cost analysis of Topical Negative Pressure (TNP) Therapy
for traumatic acquired wounds
Kostenanalyse der Vakuumtherapie für traumatische Weichteildefekte
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Zusammenfassung
Ausgedehnte traumatische Weichteildefekte erfordern aufwändige re-
konstruktive Operationsverfahren und sind von langen Liegezeiten und
RisikenwieInfektion,ThromboseundLappenverlustengekennzeichnet.
Die Vakuumtherapie (VAC) stellt dabei eine wesentliche und häufig
angewandte Therapie dar, die als kostenintensiv angesehen wird. Die
Kosten dieser Vakuumtherapie in der Behandlung des traumatischen
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Research Article OPEN ACCESSWeichteildefekts werden in der vorliegenden Arbeit mit der Methodik
der gesundheitsökonomischen Evaluation analysiert.
Alle Patienten (n=67: 45 m, 22 w; Ø 54 J.) mit traumatischem Weich-
teildefekt,diezwischen01/01/2005–31/12/2007anderUniversitäts-
klinik Göttingen mit VAC behandelt wurden, wurden in die Evaluation
eingeschlossen. Die Methode der Prozesskostenrechnung anhand Kli-
nischer Pfade, welche sich an der InEK (Institut für das Entgeltsystem
im Krankenhaus)-Systematik orientiert, war Grundlage dieser Kalkula-
tion. Zusätzlich wurde ein neues Modulsystem entwickelt, welches es
ermöglichte, individuelle Patientenkarrieren exakt abzubilden.
Die behandelten Weichteildefekte waren in 83,7% der Fälle (n=56) an
der oberen Extremität und in 16,3% der Fälle (n=11) an der unteren
Extremität lokalisiert. Die durchschnittliche Liegezeit betrug 54 Tage.
25Patienten(37,31%)überschrittendieobereGrenzverweildauerihrer
assoziierten DRG (Diagnosebezogene Fallgruppen). Der PCCL (patien-
tenbezogener Gesamtschweregrad)-Wert von 2.99 zeigt den hohen
Schweregrad dieses Kollektivs an. Für die Behandlung dieser 67 Pati-
enten entstanden Kosten von 1.249.176,91 €. Die Kosten-Erlöskalku-
lation zeigte eine Negativbilanz von –152.314,36 €. Die Kosten für die
VAC Behandlung betrugen 158,030.19 € (12,65%) mit Materialkosten-
anteil von 5,92% (74.036 €). Die Gesamtkosten pro Patient für die VAC
Therapie betrugen 2.358,66 €.
Der Hauptanteil der entstehenden Behandlungskosten bestand nicht,
wie häufig angenommen, aus den Materialkosten für die VAC Behand-
lung,sondernindenlangenLiegezeitendieserPatienten.Aufgrundihrer
Komplexität sind diese Fälle nicht adäquat in der Fallpauschalenkalku-
lationdesInEKabgebildet.EinedifferenzierteIntegrationderkomplexen
Vakuumbehandlung in das DRG-System (z.B. als erweiterte DRG I98Z)
würde die Erlössituation sachgerechter abbilden. Auch die Erstattung
ambulanter VAC Therapie würde, neben erhöhter Lebensqualität für
die Patienten, die Behandlungskosten und stationären Liegezeiten re-
duzieren.
Schlüsselwörter:Vakuumtherapie(VAC),traumatischerWeichteildefekt,
ökonomische Evaluation, Kostenanalyse
Introduction
Large traumatic wounds are frequent and cost-intensive
problems in the treatment of severely injured patients.
Theyrequireextendedreconstructiveoperationsandare
accompanied by long hospitalizations and risks of infec-
tion, thrombosis and flap-loss [1]. The topical negative
pressure (TNP) therapy provides a paradigm that can be
used in concert with a wide variety of standard existing
plastic surgery techniques [2]. It is one of the essential
methods in treatment of these wounds and has become
an integral part of the clinical routine [3]. Fleischmann
et al. [4] were the first to describe the treatment of acute
soft tissue trauma (primarily combined with open frac-
tures) with TNP.
There is a need for more economic analysis research in
plastic surgery studies [5]. The cost-effectiveness of TNP
has been evaluated in four large studies in the USA [6],
[7],[8]andtheNetherlands[9],butallofthemevaluated
chronic wounds. Until now, no economic evaluations of
treatment of traumatic wounds with TNP exist. Nord et
al. [10] describe TNP as one of the most cost-effective
methods for wound treatment. The high material costs
of TNP may be balanced by reduced nursing-costs and
reduced hospitalization-time for the patients [11]. The
morbidity and mortality after postoperative infections of
the sternum is reduced with TNP [12].
Since2004codingofTNPintheGermanDRGaccounting
system is possible with the new OPS (German Procedure
Classification)-Code5-916.a[13].Toreflectthecomplex-
ity of TNP especially in the treatment of musculoskeletal
traumatheDRGI98Zwasestablishedin2007.Untilnow,
it has been unclear whether the existing proceeding cal-
culation of the InEK (National Institute for the Hospital
RemunerationSystem)coverstheactualcostsofTNPfor
traumatic wounds.
Economic evaluation is a way of assessing medical pro-
cedures [14]. The aim is to obtain objective information
allowing for a transparent estimation of costs associated
with a medical measure [15]. This process facilitates
decisions about allocation of resources, regulation or
developmentprocesses[16].Dependentontheperspect-
ive,differentstudyprofilescanbeused:non-comparative-
studies (like “cost-analysis” or “disease-cost-analysis”)
or comparative studies like “cost-benefit-analysis” or
“cost-effective-analysis” [14]. The approval used in eval-
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uationstudiesisdefinedbythe“HannoveranerKonsens”
[15]. In our study, we used the “cost-analysis” study pro-
file measuring the concrete costs of a procedure as
activity-based costing based on clinical pathways [14].
The following questions form the basis of this evaluation
(Figure 1):
1. Whichcostsforthehospitalareassociatedwithusing
TNP treatment for traumatic acquired wounds? Are
the material costs of TNP the main component?
2. Can the cost of inpatient treatment of patients with
traumatic wounds be covered under the actual cost
revenue ratio (considering “best-case” and “worst-
case”-scenario)?
3. If necessary, are there opportunities to reduce the
costs related to TNP-therapy for traumatic wounds?
Methods
Allpatients(n=67:45male,22female;averageage54y)
with traumatically acquired wounds being treated with
TNP in the period from 01/01/2005–31/12/2007 in
the Department of Trauma Surgery, University Medicine
ofGoettingen,wereincludedinthisanalysis.Thewounds
were separated into primary tissue defects (including
open fractures, decollements, burns, and direct tissue
trauma)andsecondarytissuedefects(includingcompart-
ment syndrome, hematomas, infections, and necroses).
Inclusion criteria were the operation/procedure-keys
which can be clearly related to TNP-therapy (application
orchangeofTNPsystems)(OPS5-916.a0and5-916.a1).
Excludedfromthestudywereallpatientswithchronically
tissuedefects,multipletraumapatients(duetotheirhigh
number of concomitant diseases and injuries) and all
patients grouped in an “artificial respiration DRG” based
on long term artificial respiration.
A model for the calculation of treatment costs was de-
veloped.Closerelationtothetreatmentprocesses,calcu-
lation according to the InEK calculation systems and ad-
aptability to other groups of disease were the require-
ments for this model. An activity-based costing approach
basedonclinicalpathwayswaschosenforanappropriate
cost accounting.
Activity-based costing allocates the individual- and over-
head-costs to processes. All treatment activities were
described and evaluated in process-modules (e.g., ward
rounds, blood collection, documentation). Modules be-
longing together were combined to process-blocks (e.g.
emergencyroom,operation,ward)(Table1).Theprocess-
blocks together represent the overall process. Due to the
heterogeneity of cases, the sequence of the process-
blocks was adapted individually to each patient.
The combination of the process-blocks in relation to the
individualpatientcarriers(dependentonlengthofhospi-
talization, amount of operations or complications) repre-
sents the clinical pathway. Non-patient-related overall
costs (personnel and material costs of medical and non-
medical infrastructure) were not represented; they were
allocated using percentages as overhead costs for each
case. The clinical pathway allowed the identification of
real costs arising from TNP. The cost categories were
chosen according to the InEK-calculation-compendium
to rise comparability of measurement [17].
Thephysician-relatedactivitywascalculatedwithworking-
minutesforeveryprocess-modulesand-blocks(Table2).
For the process-block “operation” the working-minutes
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The costs of physician-related activity on the ward are calculated by multiplication of occurred process blocks during therapy with
cost/workingminute.Forcalculatingcostsoftheoperations,workingminutesofsurgeons(incl.beddingofpatients,documentation
time) and anesthesists (considering premedication, recovery room) are combined. Origin: own construction.
Table 3: Nursing-related activity; the LEP-variable groups
The nursing-related activity was collected by the LEP (detection of nursing activity) system. It is based on the daily documentation
of patient-related care variables and nursing efforts in a special software program. Origin: own construction.
were not standardized due to the individuality of the
activity. Therefore, the summarized “surgeon-presence-
time”/“cut-to-suture time”/“anesthesia-time” and the
blocks “pre-medication”/“post-op-recovery-room-time”
was calculated (Table 2).
The nursing-related activity was collected by the LEP
(detection of nursing activity) system. It is based on daily
documentation of patient-related care variables and
nursing efforts in a special software program (Table 3).
The activity of other functions and medical-technical
service(physiotherapists,patienttransportservice)were
included into overhead costs. The material costs were
calculated separately; costs of pharmaceuticals and
general medical treatment were calculated according to
the InEK calculation-system: overall costs were divided
by the LEP-hours to obtain a cost rate per LEP-hour. The
costsoftheimplants(osteosynthesismaterial)wereindi-
vidually attached to patients from the OP-information
systemandcostsweregeneratedfrompurchasingdepart-
ment. Material costs of the TNP-system were calculated
by multiplication of the day rate of TNP-therapy
(66.40 €/d for providing of the pump system and the
dressing materials) with the length of treatment.
After calculation of cost categories, they were assigned
to their particular cost unit (e.g. ward, anesthesia, radi-
ology) according to the InEK calculation-system.
To compare the expenses incurred with the incoming
revenue obtained from a funding agency a calculation of
cost per unit was performed. Six patients were chosen
as example cases and their costs were calculated. Be-
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hospitalization, one patient each was chosen with long,
medium and short hospital stays for primary and for
secondary tissue defect examples (P1, P2, P3, S1, S2,
S3).
Again, costs for physician-related activity were evaluated
byworkingminutes,multipliedbythebaserateofpre-tax
personnel costs, working hours per month and a 15%
deduction for absences from work. In this way, costs for
an assistant physician of 0.68 €/min, for a consultant
physician of 0.86 €/min and for a deputy physician of
0.95 €/min were calculated. The calculation of the
nursing-related costs was based on LEP system. For cal-
culation of the cost-group medical-technical service the
working minutes of the pathway were multiplied by the
costs/min,resultingin0.4€/min,respectively1.16€/min
for the operation-related service. Material costs were
eitherrelatedtotheLEP-hours(generalmedicaldemand)
or calculated individually (expensive implant and TNP
costs).Overheadcostsformedicalandnon-medicalinfra-
structure for the Department of Trauma Surgery, Plastic
and Reconstructive Surgery were calculated from the
University Staff Department of Central Controlling with
32–35% of total costs, due to high contingency costs for
resuscitationrooms,emergencyoperationsandinterme-
diate care ward. They were calculated as percentage ad-
ditional charge per cost unit multiplied by the cumulated
personel- and material costs (Table 4, last column, Table
5).
In addition, costs were referred and analyzed according
to the DRG earnings. The DRG-system of the year 2007
was used. All cases of 2005 and 2006 were newly
grouped using the 2007 system because the DRG I98Z
(complex negative pressure therapy of diseases and dis-
ruptionofmusculoskeletalsystemandconnectivetissue)
was not established prior to 2007.
To confirm robustness of data a sensitivity-analysis was
performed.Judgmentalparameterswerevariedtorepre-
sent the heterogeneity of the cases. In a “best-case” and
“worst-case” analysis the parameters “base-case-value”
for the funding agency and “pathway-minutes” for the
supplier were reviewed in order to determine their sen-
sitivity.
A summary of the calculation system is given in Table 4.
Thestudywascertifiedbyourinstitutionalethicscommit-
tee (AZ 13/3/08).
Results
In the period from 01/01/2005–31/12/2007, 67 pa-
tients with traumatically acquired wounds were treated
with TNP (OPS 5-916.a0 and 5-916.a1). In 30 cases
(44.8%) primary tissue defects were treated with TNP.
The predominant diagnosis was open fracture with 30%
(n=20) of all defects. Thirty-seven patients (55.2%) had
secondary tissue defects (including compartment syn-
drome, hematomas, infections and necroses). In this
group, secondary infections were the largest part due to
the extended and highly contaminated wounds, making
up 34.3% (n=23). The hospitalization time of patients
with primary tissue defects ranged from 15 d (P3) to
128 d (P1) with a mean of 39.5 d (P2). With secondary
tissuedefectspatientsstayedfrom14d(S3)to98d(S1)
withameanof38d(S2).Atotalof37.31%ofthepatients
(n=25) stayed longer than the “upper residence time”.
No patient was released from the hospital prior to the
“lowest residence time”, and 28.36% (n=19) were re-
leased before reaching the “middle residence time”. The
evaluatedcaseshadaPCCL(describesapatientseverity
score in four steps from undemanding (PCCL 0) to com-
plex, severe (PCCL 4) diseases and treatments) of 2.99,
reflecting the complex and severe nature of the cases.
To answer the questions posed in the introduction
(Figure 1), the following results can be presented (ques-
tion 3 will be answered in the Discussion):
1. During the overall treatment, the aggregated costs
fortheTNP-treatmentwere158,030.19€.Thismakes
up 12.65% of the overall costs of 1,249,227. 52 €
for complete inpatient therapy. 74,036 € of TNP re-
lated costs were generated by material costs (5.93%
oftheoverallcosts)and83,994.19€weregenerated
by personnel and operation related material costs on
ward and in operating theater (Table 6).
2. The analysis shows the actual cost of 1,249,227.52
€ for the treatment of traumatic tissue defects are
reimbursed with 1,096,913.16 €. A negative cost-
revenue ratio of –152,314.36 € remains, of which
86.23% is allotted to patients with primary tissue de-
fects. The personnel costs of physician, nursing and
medical-technical services makes up 49.75% of the
overall costs, while 17.04% is made up by material
costs. The remaining costs can be attributed to per-
sonnelandmaterialcostsofmedicalandnon-medical
infrastructure with 31.60% of overall costs
(220,072.94 €) for the collective of patients with
primary tissue defects and 35.23% of overall cost
(194,738.55 €) for the collective of patients with
secondary tissue defects (Table 6). Table 5 presents
thecalculationofoverheadcostsrelatedtothediffer-
ent length of hospital stay.
Performing the sensitivity analysis from the perspective
of the funding agency with varying “base-case-values”,
an overall cost of 993,114.2 € arises for the “best-case-
scenario” of TNP treated traumatic tissue defects. In
calculating “worst-case-scenario”, the overall costs are
1,096,698.23€.Thus,costsforthefundingagencyvary
by an absolute 106,177.99 €. The sensitivity analysis
from the point of view of the supplier depends on diver-
ging “pathway-minutes”. The variation intervals for the
pathway-minutes were calculated using a variation coef-
ficient. For the supplier (hospital) the overall costs can
be reduced by 87,829.83 € total or 1,310.89 € per case
forthe“best-case-scenario”.Forthe“worst-case-scenario”
the overall costs increase by about 81,330.59 €
total/1,213.89 € per case.
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Origin: own construction.
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Overhead costs are shown itemized for patients with different lengths of stay (P1–S3) and related to the particular cost units
(CU). Overall overhead costs are presented in Table 7. (CC=cost categories, P1–3 = patients with primary tissue defects, S1–3
= patients with secondary tissue defects). Origin: own construction.
Thus, the funding situation for the hospital even in the
“best-case-scenario”isnotcoveringthecostoftreatment.
Thelossamountsforthebest-case-scenarioto962.46€
per case and to 3.490.45 € per case for the worst-scen-
ario.
The DRG-related cost analysis is presented in Table 7; in
Table 8 the cost-revenue ratio is shown and Table 6
presents the summarized results of the cost analysis.
Discussion
Intraumapatients,primaryandsecondarytissuedefects
often require long duration of treatment. For therapy of
these traumatic wounds, TNP-therapy represents an es-
sential and frequently used technique [3]. The high cost
of medical care has come under scrutiny by payers and
physicians [18] and since the introduction of the DRG
I98Z in 2007 it remains unclear whether treatment with
TNPfortraumaticwoundscanbedoneinacost-covering
fashion.
Forthepatientcollectiveofthisstudyalltraumapatients
werechosenforwhichTNPtherapypresents,nexttotheir
osteosynthesis, a main part of their therapy. Patients
groupedina“multipletraumaDRG”and“artificialrespir-
ation DRG” were not included in the study, because TNP
therapyanditscostsplayonlyaminorroleandreimburse-
ment of such cases is calculated differently. In addition,
patients with chronical defects were also excluded due
to their high number of concomitant diseases.
1. Using methods of cost analysis, an economic evalu-
ation of this topic has been performed. For patients
with primary tissue defects the average cost was
8,279.53 € more per case than for patients with
secondary tissue defects. This additional charge re-
sults from higher material costs (absolute +
16,055.78 €), increased number of operations (on
average + 2.7 operations) as well as from elevated
number of long-term hospitalization (+ 4.86% com-
pared to patients with secondary defects). The TNP-
treatment costs of 158,030.19 € (12.65% of overall
costs) were not as high as expected, however TNP
changing was done for the main part in operation
theater. Especially TNP related material costs are of-
ten assumed to present the main fraction of TNP-
therapy, but the arising 74,036 € (5.93% of the
overall costs) can alleviate this assumption.
2. Incontrast,costsforthefundingagency(healthinsur-
ance companies) amounted to 1,096,913.16 €
leading to a financial loss of –152,314.36 €, 86.23%
of which was attributable to the treatment of primary
tissue defects. In cases of secondary tissue defects
the revenues led nearly to a cost-covering situation;
there the financial loss amounts only –20,979.22 €.
We are aware that the DRG system does not allow for
total cost coverage for every DRG. However, the
negative cost-revenue ratio of –18.86% in cases of
primary defects can hardly be compensated by DRGs
with a positive ratio.
3. Basedontheseresults,somestrategicconsequences
can be considered.
First, structural changes were performed to ensure
the efficiency: material resources were concentrated
on few storerooms to reduce the part of material not-
used and out of date. Thus, costs have already been
reduced by about 90,000 € in 2007. Due to new
contractsonthepartoftheprocurementdepartment
in 2006, another 15% of material costs could have
beensaved.*Theassumedhighmaterialcostsinthe
context of treatment with TNP often present the de-
cision criterion for the supplier. However, the
presentedanalysisshowedthatmaterialcostsofTNP
wereonlyarelativelysmallportion,makingup5.93%
of total costs. A savings opportunity should be to im-
plement a standardized approach for treatment with
TNP. Trueman et al. [11] already showed a significant
reduction in hospitalization time with a standardiza-
tion of TNP-therapy. But until now, there exist no
standardized guidelines for the use of TNP therapy
[4], [19].
Another opportunity could be the optimization of
coding procedures, but due to the presence of a
controlling specialist there are no deficits in this as-
pect in our clinic.
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(including prevalent DRG, differentiated hospitalization time, overall costs and revenues, differentiated costs with special focus
on TNP costs and overhead costs). Origin: own construction.
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Accumulated mean-calculation based on the DRG grouping systematics 2007. Origin: own construction.
Table 8: Cost-revenue ratio
The column “real revenues” contains the revenues of the years 2005, 2006 and 2007. Due to the introduction of the DRG I98Z
in2007,therevenuecalculationswereadditionallyadjustedforthisyear,showninthelasttwocolumns.Origin:ownconstruction.
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product-portfolio of the corporation (hospital) would
beanimportantsteptoremaincapableofactingand
competing. However, for a tertiary care hospital of
maximaltreatmentsuchadaptationsarenotpossible
becauseithastoprovidealldiagnosticandtherapeut-
ic possibilities. In addition, the number of complex
medical cases with severe diseases in a university
hospital is elevated, which reduces the possibilities
of cost-optimization and benchmarking [20]. A large
amount of the evaluated cases is not represented by
calculation of case-based lump sum of the InEK. The
reason could be the activity profile of the 249 partici-
pating hospitals. A strategy for improvement would
be the participation of many tertiary care hospitals in
calculationsoftheInEK.Furthermore,complexcases
couldberepresentedinanappropriatemannerinthe
DRG system.
As an important consideration, the DRG system has
todevelopcontinuouslyandlearntosustaintherising
costs. After introduction of the DRG I98Z in 2007 in
the DRG system, an adaptation and differentiation of
this DRG is necessary. Besides the complex TNP-
therapy, the new DRG should include patients with
primary tissue defects needing complex procedures.
Tissue defects cause in case of long-term therapy
extensive costs for the health insurance companies.
Thus, the discussion about refunding of outpatient
TNP-therapy has been going on for years. In cases
where it is possible from the medical point of view,
outpatient therapy would lead to enhanced quality of
life for the patients and to a reduction of hospital
costsandlengthsofhospitalization.Howeverinother
countries(USA,GreatBritain,AustriaandSwitzerland)
outpatient TNP-therapy is already an established
practice [21], the IQWIG (Institute for Quality and Effi-
ciency in Health Care, Germany) refused the absorp-
tionofoutpatientTNPtherapycostsduetoinsufficient
existing research data concerning this topic [22]. The
accomplishment of prospective randomized studies
would likely change the cost-refunding situation for
outpatient TNP-therapy.
The presented work focused on the presentation of the
developed method of gaining a cost analysis, as well as
on the analysis of the real arising costs of TNP therapy
of traumatic wounds. Therefore, we did not analyze the
surgicaltreatmentitself.However,evaluatingthenumber
of operations in the total collective, there were average
5.9 operations necessary per case (Table 7). This has to
be related to the high PCCL-level of 2.99, indicating the
severe injuries of our patients. With mostly 1–2 opera-
tions for the osteosynthesis and one operation for the fi-
nalwoundclosure,thereremainaverage3–4operations
for changing TNP dressings. Often, not only the wound
situationrequiresaconditioningaboutseveralTNPsteps,
but also the general situation of the patient is critical
(high PCCL) and does not allow extended flap surgery in
anearlystep.ThedepartmentforTraumaSurgery,Plastic
and Reconstructive Surgery, University Hospital of Goet-
tingen, as Level-A Hospital, performes their therapies
according to the current actual treatment guidelines of
the representative associations (DGOU and DGPRÄC,
GermanAssociationofOrthopaedicandTraumaSurgery,
German Association of Plastic, Reconstructive and Aes-
thetic Surgery) . So it can be assumed, that there are no
treatments performed, which would expand the arising
costsordistortortherepresentativenessoftheevaluated
results.
However,thesuppliershavetorevisecarefullytheunder-
gonetherapies.Evenifthetreatmentsweredoneaccord-
ing to established standards and guidelines, there might
beinsomecasesanopportunitytoclosethelargetissue
defects earlier by plastic-reconstructive methods. This
could reduce the length of stay of the patients and
therewiththemaincostfractionofthistreatmentcollect-
ive.
Theuseofstandardizedaccountingcanbeastrategically
effective method [23]. With the use of a disease-costing
analysis a tool of economic evaluation has been applied
toanalyzecostsofaspecialtherapy.Withinactivity-based
costing, modules for establishment of clinical pathways
were developed. On this basis, further therapies of other
diseases can be analyzed for their cost-revenue ratios.
An enhanced degree of cost-transparency can now be
reachedandrealizationoffurtheranalyseswillbesimpli-
fied.
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